Some experimental
observations indicate that a sequential formation
of secondary (2°) carbocations might be involved in some biosynthetic
pathways, including those of verrucosane-type diterpenoids and mangicol-type
sesterterpenoids, but it remains controversial whether or not such
2° cations are viable intermediates. Here, we performed comprehensive
density functional theory calculations of these biosynthetic pathways.
The results do not support previously proposed pathways/mechanisms:
in particular, we find that none of the putative 2° carbocation
intermediates is involved in either of the biosynthetic pathways.
In verrucosane biosynthesis, the proposed 2° carbocations (
II
and
IV
) in the early stage are bypassed by
the formation of the adjacent 3° carbocations and by unusual
skeletal rearrangement reactions, and in the later stage, the putative
2° carbocation intermediates (
VI
,
VII
, and
VIII
) are not present as the proposed forms but
as nonclassical structures between homoallyl and cyclopropylcarbinyl
cations. In the mangicol biosynthesis, one of the two proposed 2°
carbocations (
X
) is bypassed by a C–C bond-breaking
reaction to generate a 3° carbocation with a C=C bond,
while the other (
XI
) is bypassed by a strong hyperconjugative
interaction leading to a nonclassical carbocation. We propose new
biosynthetic pathways/mechanisms for the verrucosane-type diterpenoids
and mangicol-type sesterterpenoids. These pathways are in good agreement
with the findings of previous biosynthetic studies, including isotope-labeling
experiments and byproducts analysis, and moreover can account for
the biosynthesis of related terpenes.